| Resveratrol for cancer therapy: Challenges and future perspectives B Ren, MXY Kwah, C Liu, Z Ma, MK Shanmugam, L Ding, X Xiang, ... Cancer letters 515, 63-72, 2021 | 201 | 2021 |
| Off‐label drug use in oncology: a systematic review of literature MM Saiyed, PS Ong, L Chew Journal of clinical pharmacy and therapeutics 42 (3), 251-258, 2017 | 163 | 2017 |
| Judicious toggling of mTOR activity to combat insulin resistance and cancer: current evidence and perspectives PS Ong, LZ Wang, X Dai, SH Tseng, SJ Loo, G Sethi Frontiers in pharmacology 7, 395, 2016 | 153 | 2016 |
| Current trends in modern pharmaceutical analysis for drug discovery HL Koh, WP Yau, PS Ong, A Hegde Drug discovery today 8 (19), 889-897, 2003 | 80 | 2003 |
| Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling L Wang, NLX Syn, VV Subhash, Y Any, WL Thuya, ESH Cheow, L Kong, ... Cancer letters 417, 152-160, 2018 | 69 | 2018 |
| Celastrol in cancer therapy: Recent developments, challenges and prospects HY Lim, PS Ong, L Wang, A Goel, L Ding, ALA Wong, PC Ho, G Sethi, ... Cancer Letters 521, 252-267, 2021 | 58 | 2021 |
| Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development L Wang, J Zhang, PS Ong, WL Thuya, R Soo, ALA Wong, WP Yong, ... Oncotarget 7 (28), 44790, 2016 | 58 | 2016 |
| A review on liquid chromatography-tandem mass spectrometry methods for rapid quantification of oncology drugs ALA Wong, X Xiang, PS Ong, EQY Mitchell, N Syn, I Wee, AP Kumar, ... Pharmaceutics 10 (4), 221, 2018 | 47 | 2018 |
| A novel combinatorial strategy using Seliciclib® and Belinostat® for eradication of non-small cell lung cancer via apoptosis induction and BID activation PS Ong, L Wang, DMH Chia, JYX Seah, LR Kong, WL Thuya, ... Cancer letters 381 (1), 49-57, 2016 | 47 | 2016 |
| Differential augmentative effects of buthionine sulfoximine and ascorbic acid in As2O3-induced ovarian cancer cell death: oxidative stress-independent and-dependent cytotoxic … PS Ong, SY Chan, PC Ho International journal of oncology 38 (6), 1731-1739, 2011 | 42 | 2011 |
| Synergistic effects of suberoylanilide hydroxamic acid combined with cisplatin causing cell cycle arrest independent apoptosis in platinum-resistant ovarian cancer cells PS Ong, XQ Wang, HS Lin, SY Chan, PC Ho International journal of oncology 40 (5), 1705-1713, 2012 | 29 | 2012 |
| A miniaturized flow-through cell to evaluate skin permeation of endoxifen CS Mah, JS Kochhar, PS Ong, L Kang International journal of pharmaceutics 441 (1-2), 433-440, 2013 | 27 | 2013 |
| Association of eleven common, low-penetrance colorectal cancer susceptibility genetic variants at six risk loci with clinical outcome JM Hoskins, PS Ong, TO Keku, JA Galanko, CF Martin, CA Coleman, ... Public Library of Science 7 (7), e41954, 2012 | 26 | 2012 |
| Repurposing artemisinin and its derivatives as anticancer drugs: a chance or challenge? Z Ma, CYN Woon, CG Liu, JT Cheng, M You, G Sethi, ALA Wong, PCL Ho, ... Frontiers in Pharmacology 12, 828856, 2021 | 21 | 2021 |
| Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As2O3 and increased tumor aggressiveness in a newly established arsenic … PS Ong, SY Chan, PC Ho European journal of pharmaceutical sciences 45 (3), 367-378, 2012 | 16 | 2012 |
| Microfluidic devices for drug discovery and analysis JS Kochhar, SY Chan, PS Ong, WG Lee, L Kang Microfluidic Devices for Biomedical Applications, 231-280, 2013 | 11 | 2013 |
| Quantification of the Resveratrol Analogs trans-2,3-Dimethoxy-stilbene and trans-3,4-Dimethoxystilbene in Rat Plasma: Application to Pre-Clinical … SY Ng, N Cardullo, SCM Yeo, C Spatafora, C Tringali, PS Ong, HS Lin Molecules 19 (7), 9577-9590, 2014 | 10 | 2014 |
| Quantification of trans-2, 6-difluoro-4′-N, N-dimethylaminostilbene in rat plasma: Application to a pharmacokinetic study HS Lin, VM Sviripa, DS Watt, C Liu, TX Xiang, BD Anderson, PS Ong, ... Journal of pharmaceutical and biomedical analysis 72, 115-120, 2013 | 10 | 2013 |
| Clinical therapeutics for phenylketonuria JS Kochhar, SY Chan, PS Ong, L Kang Drug delivery and translational research 2, 223-237, 2012 | 10 | 2012 |
| Quantification of desoxyrhapontigenin (4-methoxyresveratrol) in rat plasma by LC–MS/MS: Application to pre-clinical pharmacokinetic study Y Dai, ALC Tan, H Chen, PS Ong, X Xiang, J Wu, HS Lin Journal of Pharmaceutical and Biomedical Analysis 153, 95-101, 2018 | 7 | 2018 |
